Clinical trial
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00002721
Study timeline
Study start (unknown)1995-03-01Date precision: month
Registry last updated2014-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
drug resistance inhibition treatmentPROCEDURE
Sponsors & collaborators
University of New Mexicolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002721 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.